Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. Montana Compounding Pharmacy P.C.
483
•Montana Compounding Pharmacy P.C.•September 22, 2021

Montana Compounding Pharmacy P.C. – FDA 483, Sep 22, 2021

Record Details

This FDA Form 483 documents observations from an inspection of a facility producing non-sterile drug products. The facility produced over (b)(4) non-sterile drug products in an approximately (b)(4) period, from (b)(4) to (b)(4). This included over (b)(4) highly potent drugs like testosterone, progesterone, and estrogen (e.g., RX# (b)(6) Bi-Est (8:2) - Progesterone - Testosterone 5 - 60 - 2.25 mg/gm (b)(4)), and over (b)(4) hazardous drugs such as Triodo-L-Thyronine (T3) and Thyroxine(L) (T4) (e.g., RX# (b)(6) Liothyronine Sodium (T3) 1:1000 (0.1%) (b)(4)).

The primary observation is the inadequate containment, segregation, and cleaning practices to prevent cross-contamination from highly potent and hazardous drugs. Specifically: a) The firm lacks controls, such as dedicated or segregated areas, to prevent contamination of the drug production area and cross-contamination of other drug products with highly potent and hazardous drugs. All non-sterile drugs are compounded using (b)(4) work benches, which do not adequately contain the (b)(4) bulk drug substances. b) The firm does not replace gowns between producing

Company
Montana Compounding Pharmacy P.C.
Inspection date
September 22, 2021
Product type
Drugs
Office
Seattle District Office
People
  • Kenneth O. Gee (Consumer Safety Officer)
  • Sangeeta M. Khurana (Consumer Safety Officer)
View Company Profile

ID · eef7dd20-30a5-4b54-828a-c58434c369ea

Violation Codes4
21 U.S.C. 324(a)(4)FD&C Act 905(j)FD&C Act 801(a)(3)21 CFR 331(c)

Full citation text and observation details available on the Dashboard.

Other documents for Montana Compounding Pharmacy P.C.
  • 483 - 2016-09-20September 20, 2016

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Montana Compounding Pharmacy P.C.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.